Search Results - "Brooks, DJ"

Refine Results
  1. 1
  2. 2

    Compulsive drug use linked to sensitized ventral striatal dopamine transmission by Evans, Andrew H., Pavese, Nicola, Lawrence, Andrew D., Tai, Yen F., Appel, Silke, Doder, Miroslava, Brooks, David J., Lees, Andrew J., Piccini, Paola

    Published in Annals of neurology (01-05-2006)
    “…Objective A small group of Parkinson's disease (PD) patients compulsively use dopaminergic drugs despite causing harmful social, psychological, and physical…”
    Get full text
    Journal Article
  3. 3

    The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study by von Spiczak, Sarah, Whone, Alan L., Hammers, Alexander, Asselin, Marie-Claude, Turkheimer, Federico, Tings, Tobias, Happe, Svenja, Paulus, Walter, Trenkwalder, Claudia, Brooks, David J.

    Published in Brain (London, England : 1878) (01-04-2005)
    “…Opioids have been shown to provide symptomatic relief from dysaesthesias and motor symptoms in restless legs syndrome (RLS). However, the mechanisms by which…”
    Get full text
    Journal Article
  4. 4

    Reward Processing in Health and Parkinson’s Disease: Neural Organization and Reorganization by Goerendt, Ines K., Lawrence, Andrew D., Brooks, David J.

    Published in Cerebral cortex (New York, N.Y. 1991) (01-01-2004)
    “…It has been suggested that motivational processes mediated by dopaminergic neural systems may be relatively spared in Parkinson’s disease (PD) and activation…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum by Jansen, Willemijn J, Janssen, Olin, Tijms, Betty M, Vos, Stephanie J B, Ossenkoppele, Rik, Visser, Pieter Jelle, Aarsland, Dag, Alcolea, Daniel, Altomare, Daniele, von Arnim, Christine, Baiardi, Simone, Baldeiras, Ines, Barthel, Henryk, Bateman, Randall J, Van Berckel, Bart, Binette, Alexa Pichet, Blennow, Kaj, Boada, Merce, Boecker, Henning, Bottlaender, Michel, den Braber, Anouk, Brooks, David J, Van Buchem, Mark A, Camus, Vincent, Carill, Jose Manuel, Cerman, Jiri, Chen, Kewei, Chételat, Gaël, Chipi, Elena, Cohen, Ann D, Daniels, Alisha, Delarue, Marion, Didic, Mira, Drzezga, Alexander, Dubois, Bruno, Eckerström, Marie, Ekblad, Laura L, Engelborghs, Sebastiaan, Epelbaum, Stéphane, Fagan, Anne M, Fan, Yong, Fladby, Tormod, Fleisher, Adam S, Van der Flier, Wiesje M, Förster, Stefan, Fortea, Juan, Frederiksen, Kristian Steen, Freund-Levi, Yvonne, Frings, Lars, Frisoni, Giovanni B, Fröhlich, Lutz, Gabryelewicz, Tomasz, Gertz, Hermann-Josef, Gill, Kiran Dip, Gkatzima, Olymbia, Gómez-Tortosa, Estrella, Grimmer, Timo, Guedj, Eric, Habeck, Christian G, Hampel, Harald, Handels, Ron, Hansson, Oskar, Hausner, Lucrezia, Hellwig, Sabine, Heneka, Michael T, Herukka, Sanna-Kaisa, Hildebrandt, Helmut, Hodges, John, Hort, Jakub, Huang, Chin-Chang, Iriondo, Ane Juaristi, Itoh, Yoshiaki, Ivanoiu, Adrian, Jagust, William J, Jessen, Frank, Johannsen, Peter, Johnson, Keith A, Kandimalla, Ramesh, Kapaki, Elisabeth N, Kern, Silke, Kilander, Lena, Klimkowicz-Mrowiec, Aleksandra, Klunk, William E, Koglin, Norman, Kornhuber, Johannes, Kramberger, Milica G, Kuo, Hung-Chou, Van Laere, Koen, Landau, Susan M, Landeau, Brigitte, Lee, Dong Young, de Leon, Mony, Leyton, Cristian E, Lin, Kun-Ju, Lleó, Alberto, Löwenmark, Malin, Madsen, Karine, Maier, Wolfgang, Marcusson, Jan, Marquié, Marta

    Published in JAMA neurology (01-03-2022)
    “…One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal…”
    Get more information
    Journal Article
  9. 9

    The noradrenergic subtype of Parkinson disease: from animal models to clinical practice by Ray Chaudhuri, K., Leta, Valentina, Bannister, Kirsty, Brooks, David J., Svenningsson, Per

    Published in Nature reviews. Neurology (01-06-2023)
    “…Many advances in understanding the pathophysiology of Parkinson disease (PD) have been based on research addressing its motor symptoms and phenotypes. Various…”
    Get full text
    Journal Article
  10. 10

    Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial by Rascol, O, Brooks, DJ, Melamed, E, Oertel, W, Poewe, W, Stocchi, F, Tolosa, E

    Published in The Lancet (British edition) (12-03-2005)
    “…Rasagiline mesylate is a novel drug for Parkinson's disease with selective, irreversible monoamine oxidase B (MAO-B) inhibitor activity, and is effective as…”
    Get full text
    Journal Article
  11. 11
  12. 12

    In vivo imaging of microglial activation with [ 11C]( R)-PK11195 PET in idiopathic Parkinson's disease by Gerhard, Alexander, Pavese, Nicola, Hotton, Gary, Turkheimer, Federico, Es, Meltem, Hammers, Alexander, Eggert, Karla, Oertel, Wolfgang, Banati, Richard B., Brooks, David J.

    Published in Neurobiology of disease (01-02-2006)
    “…Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder associated with akinesia, tremor and rigidity. While the characteristic Lewy body pathology…”
    Get full text
    Journal Article
  13. 13

    Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease by Martinez-Martin, Pablo, Falup Pecurariu, Cristian, Odin, Per, van Hilten, Jacobus J., Antonini, Angelo, Rojo-Abuin, Jose M., Borges, Vanderci, Trenkwalder, Claudia, Aarsland, Dag, Brooks, David J., Ray Chaudhuri, Kallol

    Published in Journal of neurology (01-08-2012)
    “…Differences in the expression of non-motor symptoms (NMS) by Parkinson’s disease (PD) patients may have important implications for their management and…”
    Get full text
    Journal Article
  14. 14

    Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted mice by Devlin, M J, Brooks, D J, Conlon, C, Vliet, M van, Louis, L, Rosen, C J, Bouxsein, M L

    Published in Journal of endocrinology (01-06-2016)
    “…Starvation induces low bone mass and high bone marrow adiposity in humans, but the underlying mechanisms are poorly understood. The adipokine leptin falls in…”
    Get full text
    Journal Article
  15. 15

    Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease by Mattsson, Niklas, Groot, Colin, Jansen, Willemijn J., Landau, Susan M., Villemagne, Victor L., Engelborghs, Sebastiaan, Mintun, Mark M., Lleo, Alberto, Molinuevo, José Luis, Jagust, William J., Frisoni, Giovanni B., Ivanoiu, Adrian, Chételat, Gaël, Resende de Oliveira, Catarina, Rodrigue, Karen M., Kornhuber, Johannes, Wallin, Anders, Klimkowicz-Mrowiec, Aleksandra, Kandimalla, Ramesh, Popp, Julius, Aalten, Pauline P., Aarsland, Dag, Alcolea, Daniel, Almdahl, Ina S., Baldeiras, Inês, van Buchem, Mark A., Cavedo, Enrica, Chen, Kewei, Cohen, Ann D., Förster, Stefan, Fortea, Juan, Frederiksen, Kristian S., Freund-Levi, Yvonne, Gill, Kiran Dip, Gkatzima, Olymbia, Grimmer, Timo, Hampel, Harald, Herukka, Sanna-Kaisa, Johannsen, Peter, van Laere, Koen, de Leon, Mony J., Maier, Wolfgang, Marcusson, Jan, Meulenbroek, Olga, Møllergård, Hanne M., Morris, John C., Mroczko, Barbara, Nordlund, Arto, Prabhakar, Sudesh, Peters, Oliver, Rami, Lorena, Rodríguez-Rodríguez, Eloy, Roe, Catherine M., Rüther, Eckart, Santana, Isabel, Schröder, Johannes, Seo, Sang W., Soininen, Hilkka, Spiru, Luiza, Stomrud, Erik, Struyfs, Hanne, Teunissen, Charlotte E., Verhey, Frans R.J., Vos, Stephanie J.B., van Waalwijk van Doorn, Linda J.C., Waldemar, Gunhild, Wallin, Åsa K., Wiltfang, Jens, Vandenberghe, Rik, Brooks, David J., Fladby, Tormod, Rowe, Christopher C., Drzezga, Alexander, Verbeek, Marcel M., Sarazin, Marie, Wolk, David A., Fleisher, Adam S., Klunk, William E., Na, Duk L., Sánchez-Juan, Pascual, Lee, Dong Young, Nordberg, Agneta, Tsolaki, Magda, Camus, Vincent, Rinne, Juha O., Fagan, Anne M., Zetterberg, Henrik, Blennow, Kaj, Rabinovici, Gil D., Hansson, Oskar, van Berckel, Bart N.M., van der Flier, Wiesje M., Scheltens, Philip, Visser, Pieter Jelle, Ossenkoppele, Rik

    Published in Alzheimer's & dementia (01-07-2018)
    “…Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its prevalence is unclear because earlier studies did not require…”
    Get full text
    Journal Article
  16. 16

    Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe by Hammers, Alexander, Allom, Richard, Koepp, Matthias J., Free, Samantha L., Myers, Ralph, Lemieux, Louis, Mitchell, Tejal N., Brooks, David J., Duncan, John S.

    Published in Human brain mapping (01-08-2003)
    “…Probabilistic atlases of neuroanatomy are more representative of population anatomy than single brain atlases. They allow anatomical labeling of the results of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease by Gill, Steven S, Svendsen, Clive N, Patel, Nikunj K, Hotton, Gary R, O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J, Heywood, Peter

    Published in Nature medicine (01-05-2003)
    “…Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor with restorative effects in a wide variety of rodent and primate models of…”
    Get full text
    Journal Article
  19. 19

    Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study by Whone, Alan L., Watts, Ray L., Stoessl, A. Jon, Davis, Margaret, Reske, Sven, Nahmias, Claude, Lang, Anthony E., Rascol, Olivier, Ribeiro, Maria J., Remy, Philippe, Poewe, Werner H., Hauser, Robert A., Brooks, David J.

    Published in Annals of neurology (01-07-2003)
    “…Preclinical studies suggest ropinirole (a D2/D3 dopamine agonist) may be neuroprotective in Parkinson's disease (PD), and a pilot clinical study using 18F‐dopa…”
    Get full text
    Journal Article
  20. 20

    Positron Emission Tomography and Single-Photon Emission Computed Tomography in Central Nervous System Drug Development by Brooks, David J.

    Published in NeuroRx (01-04-2005)
    “…In this review, the value of functional imaging [positron emission tomography (PET)/single-photon emission computed tomography (SPECT)] in drug development is…”
    Get full text
    Journal Article